Amidst growing cases of corona in the country, Member of the NITI Aayog, Dr. VK Paul said that the sale of Sputnik-V vaccine will start in India from next week. While giving another big information, he said that production of this vaccine will also start in India from July. Along with this, he said that any vaccine company approved by FDA, WHO can come to India. Import license will be given within 1-2 days.
Sputnik V is the third vaccine India has given go-ahead to after Covishield and Covaxin. Covishield is developed by AstraZeneca and manufactured by the Serum Institute in India locally.
Addressing a briefing on the vaccination situation in the country, Dr Paul said that the central government has already procured 350 million vaccine doses for the ongoing vaccination drive and more than 2 billion vaccine doses will be manufactured between August and December.
What's Your Reaction?
Founded in May 2018 in Bangkok, Thailand, Indo Thai News has been conceived with an aim of fostering Travel & Tourism between the two amazing countries, India & Thailand.